Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001193125-25-049889
Filing Date
2025-03-07
Accepted
2025-03-07 16:15:52
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B7 d940369d424b7.htm 424B7 235122
2 EX-FILING FEES d940369dexfilingfees.htm   iXBRL EX-FILING FEES 47248
3 GRAPHIC g940369g00a26.jpg GRAPHIC 63475
  Complete submission text file 0001193125-25-049889.txt   506057

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d940369dexfilingfees_htm.xml XML 6836
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 424B7 | Act: 33 | File No.: 333-268665 | Film No.: 25720277
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)